ShareValue scores for 0QKQ.LSE: Valuation 50, Quality 15, Growth 21, Health 42.
0QKQ.LSELSE
RELIEF THERAPEUTICS Holding AG
£0.00
(+9.75%)
0QKQ.LSELSE
RELIEF THERAPEUTICS Holding AG
£0.00(+9.75%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Weak
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
3% to 16%
Rating
Trap Risk
Return
3% to 16%
Valuation
50
Fair Value
Price vs Value
Quality
15
Weak
Business Strength
Growth
21
Weak
Revenue & Earnings
Health
42
Moderate
Financial Stability
Momentum
0
Bearish
Price Trend
Company Details
About
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
Sector
IndustryN/A
ExchangeLSE
Market Cap$2M
P/E RatioN/A
Dividend YieldNone
Sector Rank#2217
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026